Precigen slumps ~15% on pricing $75M common stock offering
cemagraphics
- Precigen (NASDAQ:PGEN) priced an offering of ~42.86M common shares at $1.75 apiece to raise about $75M in gross proceeds.
- The company also granted the underwriters a 30-day option to buy up to an additional ~6.43M shares.
- Precigen plans to use the net proceeds for developing clinical and preclinical candidates, for working capital and other general corporate purposes.
- The offering is expected to close on Jan. 27
- PGEN -16.44% to $1.83 premarket Jan. 25